Abbott Recalls A Batch Of Thyroid Disorder Drug For Labelling Error
Listen to This Article
Abbott India has recalled one batch of its popular thyroid disorder drug Thyronorm due to a labeling error about dosage, saying there was no quality issue.
The mislabeled batch was invoiced in Madhya Pradesh and Telangana. “Abbott is recalling one batch (No. AEJ0713; Mfg. Date: March 2023) of Thyronorm, a medicine used in the treatment of hypothyroidism, in India, due to a labeling error that mislabeled the dose strength (mcg or microgram),” said the pharmaceutical company.
“There are no quality issues with the product, and we haven’t received any reports of patient impact. A small percentage of bottles from the concerned batch (No. AEJ0713) of 88mcg tablets have an incorrect 25mcg label. It is important that people take the correct dose, so we have initiated a voluntary recall of the mislabeled batch,” it said.
The company said it is working with distributors to facilitate the recall. “This issue does not affect or extend to any other batch or dosage strength of Thyronorm or other Abbott products.”
Thyronorm is prescribed to patients with hypothyroidism, a condition where the thyroid gland does not produce sufficient quantities of the required hormones. Deficiency of thyroid hormones can disrupt heart rate, body temperature and metabolism. Hypothyroidism is most prevalent in older women. Major symptoms include fatigue, cold sensitivity, constipation, dry skin and unexplained weight gain.
An overdose of the medication can cause chest pain, irregular heartbeats, headache, muscle cramps, anxiety, sweating, diarrhoea, sleeplessness, etc.
According to IQVIA, Thyronorm is the eighth largest selling drug brand in India as of March 2023 with sales of Rs 564.73 crore according to moving annual turnover (MAT) data.
Titi Coles Legacy In Finance: Pioneering Diversity And Leadership
Titi Cole, one of the most senior Black women in the world of finance, recently exited her high-profile role at Citi. He... Read more
Rising Rates, Rising Challenges: Bankers Adapt To Serve Troubled Companies In A Changing Economic Landscape
As interest rates climb, troubled companies are facing heightened financial pressures, prompting them to seek assistance... Read more
The Elusive Nature Of Fraud Detection: Exploring The Auditor's Dilemma
In the intricate world of financial reporting, auditors serve as guardians of integrity, tasked with uncovering discrepa... Read more
The Battle For Depositors: US Lenders Ramp Up Efforts Amidst Rate Uncertainty
In the competitive landscape of the US banking sector, retaining depositors is paramount for lenders seeking to maintain... Read more
Beyond Capital: Unveiling The Complexities Of Bank Failure Prediction
In the realm of banking, the ability to predict and prevent failures is paramount for financial stability and consumer c... Read more
Central Banks And The Economic Horizon: Steering Through Uncertaintie
In the evolving landscape of global financial markets, the strategic role of central banks has come under intense scruti... Read more